肿瘤微环境
癌症研究
下调和上调
达沙替尼
PI3K/AKT/mTOR通路
腺癌
生物
蛋白激酶B
细胞因子
免疫学
信号转导
癌症
细胞生物学
基因
肿瘤细胞
遗传学
髓系白血病
伊马替尼
作者
Yin Li,Manling Jiang,Ling Aye,Li Luo,Yong Zhang,Fengkai Xu,Yongqi Wei,Dan Peng,Xiang He,Jie Gu,Xiaofang Yu,Guoping Li,Di Ge,Di Ge
标识
DOI:10.1038/s41467-024-45340-w
摘要
Abstract The complexity of the tumor microenvironment (TME) is a crucial factor in lung adenocarcinoma (LUAD) progression. To gain deeper insights into molecular mechanisms of LUAD, we perform an integrative single-cell RNA sequencing (scRNA-seq) data analysis of 377,574 cells from 117 LUAD patient samples. By linking scRNA-seq data with bulk gene expression data, we identify a cluster of prognostic-related UPP1 high tumor cells. These cells, primarily situated at the invasive front of tumors, display a stronger association with the immunosuppressive components in the TME. Our cytokine array analysis reveals that the upregulation of UPP1 in tumor cells leads to the increased release of various immunosuppressive cytokines, with TGF-β1 being particularly prominent. Furthermore, this UPP1 upregulation also elevates the expression of PD-L1 through the PI3K/AKT/mTOR pathway, which contributes to the suppression of CD8 + T cells. Cytometry by time-of-flight (CyTOF) analysis provides additional evidence of the role of UPP1 in shaping the immunosuppressive nature of the TME. Using patient-derived organoids (PDOs), we discover that UPP1 high tumors exhibit relatively increased sensitivity to Bosutinib and Dasatinib. Collectively, our study highlights the immunosuppressive role of UPP1 in LUAD, and these findings may provide insights into the molecular features of LUAD and facilitate the development of personalized treatment strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI